Mukhtar, S., and M. Haris. “Teplizumab: An FDA- Approved Drug, Marks Milestone in Treatment of Type 1 Diabetes”. International Journal of Scientific Reports, vol. 10, no. 1, Dec. 2023, pp. 29-30, doi:10.18203/issn.2454-2156.IntJSciRep20233870.